2016년 11월 말 현재 바이오, 의료 3,962억 원, ICT 서비스 3,494억 원 순으로 신규 투자가 됐다.
As of the end of November 2016, new investments were made in the order of biomedical and medical services of KRW 396.2 billion and ICT services of KRW 349.4 billion.